scholarly journals Methodical Challenges and a Possible Resolution in the Assessment of Receptor Reserve for Adenosine, an Agonist with Short Half-Life

Molecules ◽  
2017 ◽  
Vol 22 (5) ◽  
pp. 839 ◽  
Author(s):  
Judit Zsuga ◽  
Tamas Erdei ◽  
Katalin Szabó ◽  
Nora Lampe ◽  
Csaba Papp ◽  
...  
1977 ◽  
Vol 16 (04) ◽  
pp. 157-162 ◽  
Author(s):  
C. Schümichen ◽  
B. Mackenbrock ◽  
G. Hoffmann

SummaryThe bone-seeking 99mTc-Sn-pyrophosphate compound (compound A) was diluted both in vitro and in vivo and proved to be unstable both in vitro and in vivo. However, stability was much better in vivo than in vitro and thus the in vitro stability of compound A after dilution in various mediums could be followed up by a consecutive evaluation of the in vivo distribution in the rat. After dilution in neutral normal saline compound A is metastable and after a short half-life it is transformed into the other 99mTc-Sn-pyrophosphate compound A is metastable and after a short half-life in bone but in the kidneys. After dilution in normal saline of low pH and in buffering solutions the stability of compound A is increased. In human plasma compound A is relatively stable but not in plasma water. When compound B is formed in a buffering solution, uptake in the kidneys and excretion in urine is lowered and blood concentration increased.It is assumed that the association of protons to compound A will increase its stability at low concentrations while that to compound B will lead to a strong protein bond in plasma. It is concluded that compound A will not be stable in vivo because of a lack of stability in the extravascular space, and that the protein bond in plasma will be a measure of its in vivo stability.


Mitochondrion ◽  
2015 ◽  
Vol 21 ◽  
pp. 27-32 ◽  
Author(s):  
Yang Xu ◽  
Ashim Malhotra ◽  
Steven M. Claypool ◽  
Mindong Ren ◽  
Michael Schlame

1998 ◽  
Vol 84 (2) ◽  
pp. 435-441 ◽  
Author(s):  
Christophe Adrie ◽  
Fumito Ichinose ◽  
Alexandra Holzmann ◽  
Larry Keefer ◽  
William E. Hurford ◽  
...  

Adrie, Christophe, Fumito Ichinose, Alexandra Holzmann, Larry Keefer, William E. Hurford, and Warren M. Zapol. Pulmonary vasodilation by nitric oxide gas and prodrug aerosols in acute pulmonary hypertension. J. Appl. Physiol. 84(2): 435–441, 1998.—Sodium 1-( N, N-diethylamino)diazen-1-ium-1,2-diolate {DEA/NO; Et2N[N(O)NO]Na} is a compound that spontaneously generates nitric oxide (NO). Because of its short half-life (2.1 min), we hypothesized that inhaling DEA/NO aerosol would selectively dilate the pulmonary circulation without decreasing systemic arterial pressure. We compared the pulmonary selectivity of this new NO donor with two other reference drugs: inhaled NO and inhaled sodium nitroprusside (SNP). In seven awake sheep with pulmonary hypertension induced by the infusion of U-46619, we compared the hemodynamic effects of DEA/NO with those of incremental doses of inhaled NO gas. In seven additional awake sheep, we examined the hemodynamic effects of incremental doses of inhaled nitroprusside (i.e., SNP). Inhaled NO gas selectively dilated the pulmonary vasculature. Inhaled DEA/NO produced nonselective vasodilation; both systemic vascular resistance (SVR) and pulmonary vascular resistance (PVR) were reduced. Inhaled SNP selectively dilated the pulmonary circulation at low concentrations (≤10−2 M), inducing a decrease of PVR of up to 42% without any significant decrease of SVR (−5%), but nonselectively dilated the systemic circulation at larger doses (>10−2 M). In conclusion, despite its short half-life, DEA/NO is not a selective pulmonary vasodilator compared with inhaled NO. Inhaled SNP appears to be selective to the pulmonary circulation at low doses but not at higher levels.


2008 ◽  
Vol 24 (2) ◽  
pp. 89-98 ◽  
Author(s):  
V. F. Gopka ◽  
A. V. Yushchenko ◽  
V. A. Yushchenko ◽  
I. V. Panov ◽  
Ch. Kim

2015 ◽  
Vol 31 (8) ◽  
pp. 1074.e7 ◽  
Author(s):  
Francesco Santoro ◽  
Riccardo Ieva ◽  
Matteo Di Biase ◽  
Natale Daniele Brunetti

1987 ◽  
Vol 25 (26) ◽  
pp. 103.1-103

A letter to the Lancet (S S Adams, 21 Nov 1987, 1204–5) points out that when the CSM adverse reactions data for the 11 NSAIDs cited in our table are ranked in descending order of toxicity, nearly all those with a long plasma elimination half-life of about 10 hours or more (for the drug + active metabolites) come at the top of the list. The other compounds have a short half-life, 4 hours or less. The table below shows the relevant CSM data rearranged in rank order, and the approximate half-lives of the drugs. Half-lives vary widely between patients and tend to be longer in the elderly. Toxicity is obviously not determined by slow elimination alone, but prolonged high concentrations of a drug in the tissues are likely to exacerbate any toxic effects. Short-acting drugs may allow some recovery between doses from the potentially damaging inhibition of prostaglandin synthesis at vulnerable sites, such as the gut and kidney. NSAIDs with a short half-life should therefore be preferred unless a somewhat longer action is needed to alleviate morning stiffness. Sustained-release forms of NSAIDs with an otherwise short half-life should also be used cautiously.


2020 ◽  
Vol 82 (2) ◽  
pp. 72-79
Author(s):  
Philip J. Senter

The recent discovery of radiocarbon in dinosaur bones at first seems incompatible with an age of millions of years, due to the short half-life of radiocarbon. However, evidence from isotopes other than radiocarbon shows that dinosaur fossils are indeed millions of years old. Fossil bone incorporates new radiocarbon by means of recrystallization and, in some cases, bacterial activity and uranium decay. Because of this, bone mineral – fossil or otherwise – is a material that cannot yield an accurate radiocarbon date except under extraordinary circumstances. Mesozoic bone consistently yields a falsely young radiocarbon “date” of a few thousand to a few tens of thousands of years, despite the fact that it is millions of years old. Science educators need to be aware of the details of these phenomena, to be able to advise students whose acceptance of biological evolution has been challenged by young-Earth creationist arguments that are based on radiocarbon in dinosaur fossils.


RSC Advances ◽  
2016 ◽  
Vol 6 (80) ◽  
pp. 76621-76631 ◽  
Author(s):  
Manu Sharma ◽  
Namita Gupta ◽  
Sumeet Gupta

The major obstacles for treatment of intracellular infections with clarithromycin are poor gastrointestinal solubility, short half-life (3–4 h), low oral bioavailability and hepatotoxicity.


Sign in / Sign up

Export Citation Format

Share Document